Leukemia is a cancer of blood-forming tissues, hindering the body's ability to fight infection. Cancer specialists at SIU HealthCare employ the most advanced therapies and treatments in combatting this disease.
Examining the safety, tolerability, and effectiveness of investigational drug ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia. The study drug will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.
